Effects of growth hormone on glucose metabolism and insulin resistance in human

논문상세정보
    • 저자 김신혜 박미정
    • 제어번호 104940409
    • 학술지명 Annals of Pediatirc Endocrinology & Metabolism
    • 권호사항 Vol. 22 No. 3 [ 2017 ]
    • 발행처 대한소아내분비학회
    • 발행처 URL http://www.kspendo.or.kr
    • 자료유형 학술저널
    • 수록면 145-152
    • 언어 English
    • 출판년도 2017
    • 등재정보 KCI등재
    • 판매처
    유사주제 논문( 0)

' Effects of growth hormone on glucose metabolism and insulin resistance in human' 의 참고문헌

  • The safety profile of GH replacement therapy in adults
    Chipman JJ Clin Endocrinol (Oxf) 46 473-481 [1997]
  • The novel roles of liver for compensation of insulin resistance in human growth hormone transgenic rats
    Cho Y Endocrinology 147 5374-5384 [2006]
  • The intricate role of growth hormone in metabolism
    Vijayakumar A Front Endocrinol (Lausanne) 2 32- [2011]
  • The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients
    Gibney J J Clin Endocrinol Metab 84 2596-2602 [1999]
  • The effect of growth hormone (GH) replacement on blood glucose homeostasis in adult nondiabetic patients with GH deficiency: real-life data from the NordiNet(R) International Outcome Study
    Weber MM Clin Endocrinol (Oxf) 86 192-198 [2017]
  • The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults
    Rosenfalck AM J Clin Endocrinol Metab 85 4173-4181 [2000]
  • Short-term, low-dose GH therapy improves insulin sensitivity without modifying cortisol metabolism and ectopic fat accumulation in adults with GH deficiency
    Yuen KC J Clin Endocrinol Metab 99 E1862-E1869 [2014]
  • Safety of recombinant deoxyribonucleic acid-derived growth hormone: The National Cooperative Growth Study experience
    Blethen SL J Clin Endocrinol Metab 81 1704-1710 [1996]
  • SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms
    Ram PA J Biol Chem 274 35553-35561 [1999]
  • SOCS- 1 and SOCS-3 block insulin signaling by ubiquitinmediated degradation of IRS1 and IRS2
    Rui L J Biol Chem 277 42394-42398 [2002]
  • Role of intramyocelluar lipids in human health
    Coen PM Trends Endocrinol Metab 23 391-398 [2012]
  • Risk of diabetes treated in early adulthood after growth hormone treatment of short stature in childhood
    Poidvin A J Clin Endocrinol Metab 102 1291-1298 [2017]
  • Revaluation of the clinical and metabolic behavior of children with isolated growth hormone deficiency during GH treatment according to newly proposed note 39 of the Italian Medicines Agency (AIFA)
    Ciresi A J Endocrinol Invest 38 1301-1307 [2015]
  • Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes
    Moses AC Diabetes 45 91-100 [1996]
  • Prospective safety surveillance of GHdeficient adults: comparison of GH-treated vs untreated patients
    Hartman ML J Clin Endocrinol Metab 98 980-988 [2013]
  • Prevalence and incidence of diabetes mellitus in adult patients on growth hormone replacement for growth hormone deficiency: a surveillance database analysis
    Attanasio AF J Clin Endocrinol Metab 96 2255-2261 [2011]
  • Prevalence and incidence of diabetes mellitus in GH-treated children and adolescents: analysis from the GeNeSIS observational research program
    Child CJ J Clin Endocrinol Metab 96 E1025-E1034 [2011]
  • Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency
    Yuen KC Clin Endocrinol (Oxf) 64 549-555 [2006]
  • Orphan nuclear receptor small heterodimer partner negatively regulates growth hormone-mediated induction of hepatic gluconeogenesis through inhibition of signal transducer and activator of transcription 5 (STAT5) transactivation
    Kim YD J Biol Chem 287 37098-37108 [2012]
  • Occurrence of impaired fasting glucose in GH-deficient adults receiving GH replacement compared with untreated subjects
    Woodmansee WW Clin Endocrinol (Oxf) 72 59-69 [2010]
  • Metabolic parameters and adipokine profile in growth hormone deficient (GHD) children before and after 12-month GH treatment
    Meazza C Horm Metab Res 46 219-223 [2014]
  • Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1
    LeRoith D Nat Clin Pract Endocrinol Metab 3 302-310 [2007]
  • Long-term monitoring of insulin sensitivity in growth hormone-deficient adults on substitutive recombinant human growth hormone therapy
    Giavoli C Metabolism 53 740-743 [2004]
  • Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover
    Unger RH Diabetes 50 Suppl 1 S118-S121 [2001]
  • Insulin sensitivity in growth hormonedeficient children: influence of replacement treatment
  • Insulin and insulin-like growth factor-1 receptors act as ligand-specific amplitude modulators of a common pathway regulating gene transcription
    Boucher J J Biol Chem 285 17235-17245 [2010]
  • Insulin and GH signaling in human skeletal muscle in vivo following exogenous GH exposure: impact of an oral glucose load
    Krusenstjerna-Hafstrom T PLoS One 6 e19392- [2011]
  • Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment
    Cutfield WS Lancet 355 610-613 [2000]
  • Incidence of diabetes mellitus and evolution of glucose parameters in growth hormone-deficient subjects during growth hormone replacement therapy: a long-term observational study
    Luger A Diabetes Care 35 57-62 [2012]
  • Improvement of cardiac performance and cardiovascular risk factors in children with GH deficiency after two years of GH replacement therapy: an observational, open, prospective, case-control study
    Salerno M J Clin Endocrinol Metab 91 1288-1295 [2006]
  • Human placental growth hormone increases expression of the p85 regulatory unit of phosphatidylinositol 3-kinase and triggers severe insulin resistance in skeletal muscle
    Barbour LA Endocrinology 145 1144-1150 [2004]
  • Growth hormone replacement therapy induces insulin resistance by activating the glucosefatty acid cycle
    Bramnert M J Clin Endocrinol Metab 88 1455-1463 [2003]
  • Growth hormone regulation of p85alpha expression and phosphoinositide 3-kinase activity in adipose tissue: mechanism for growth hormone-mediated insulin resistance
    del Rincon JP Diabetes 56 1638-1646 [2007]
  • Growth hormone receptor regulates beta cell hyperplasia and glucose-stimulated insulin secretion in obese mice
    Wu Y J Clin Invest 121 2422-2426 [2011]
  • Growth hormone (GH) replacement reduces total body fat and normalizes insulin sensitivity in GH-deficient adults: a report of one-year clinical experience
    Hwu CM J Clin Endocrinol Metab 82 3285-3292 [1997]
  • Fifteen years of GH replacement improves body composition and cardiovascular risk factors
    Elbornsson M Eur J Endocrinol 168 745-753 [2013]
  • Fatty acids and insulin resistance in muscle and liver
    Kovacs P Best Pract Res Clin Endocrinol Metab 19 625-635 [2005]
  • Evaluation of left ventricular mass and function, lipid profile, and insulin resistance in Egyptian children with growth hormone deficiency: A single-center prospective casecontrol study
    Metwalley KA Indian J Endocrinol Metab 17 876-882 [2013]
  • Efficacy and safety of growth hormone replacement therapy in Japanese adults with growth hormone deficiency: a post-marketing observational study
    Shimatsu A Endocr J 60 1131-1144 [2013]
  • Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency
    Fowelin J Metabolism 42 1443-1447 [1993]
  • Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults
    Svensson J J Clin Endocrinol Metab 87 2121-2127 [2002]
  • Effects of recombinant human growth hormone on hepatic lipid and carbohydrate metabolism in HIV-infected patients with fat accumulation
    Schwarz JM J Clin Endocrinol Metab 87 942- [2002]
  • Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects
    Moller N Endocr Rev 30 152-177 [2009]
  • Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial
    Sesmilo G Ann Intern Med 133 111-122 [2000]
  • Effects of four years' treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults
    al-Shoumer KA Clin Endocrinol (Oxf) 48 795-802 [1998]
  • Effects of 7 years of growth hormone replacement therapy in hypopituitary adults
    Chrisoulidou A J Clin Endocrinol Metab 85 3762-3769 [2000]
  • Divergent regulation of rat adipocyte GLUT1 and GLUT4 glucose transporters by GH
    Kilgour E J Endocrinol 145 27-33 [1995]
  • Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy
    Christopher M J Clin Endocrinol Metab 83 1668-1681 [1998]
  • Decreased insulin sensitivity and compensatory hyperinsulinemia after hormone treatment in children with short stature
    Heptulla RA J Clin Endocrinol Metab 82 3234-3238 [1997]
  • Cross-sectional and prospective study of the effects of GH therapy on metabolic panel in children with GH deficiency
    Ramistella V Pediatr Med Chir 36 104- [2014]
  • Contribution of gluconeogenesis and glycogenolysis to hepatic glucose production in acromegaly before and after pituitary microsurgery
    Hoybye C Horm Metab Res 40 498-501 [2008]
  • Comparison of glucose and lipid metabolism and bone mineralization in patients with growth hormone deficiency with and without long-term growth hormone replacement
    Roemmler J Metabolism 59 350-358 [2010]
  • Carbohydrate metabolism in children receiving growth hormone for 5 years. Chronic renal insufficiency compared with growth hormone deficiency, Turner syndrome, and idiopathic short stature
    Saenger P Genentech Collaborative Group. Pediatr Nephrol 10 261-263 [1996]
  • Are the metabolic effects of GH and IGF-I separable
    Mauras N Growth Horm IGF Res 15 19-27 [2005]